A groundbreaking study reveals how a rare combination of genetics, proteomics, and environmental factors may hold the key to ...

Researchers develop early Alzheimers diagnostic method using tau protein analysis Advancements in Alzheimers detection reveal ...

Failed to fetch dynamically imported module: https://finance.yahoo.com/assets/_app/immutable/nodes/2.3cY8rBmp.js ...

Exenatide had no disease-modifying effects in a phase 3 trial Parkinson’s disease, despite earlier evidence from a phase 2 ...

Jan. 13, 2025 — Researchers have uncovered novel insights into how brain function disruptions related to cerebrovascular disease ... dementia, researchers and clinicians typically rely on MRI ...

A woman who is at least the fourth generation of her family to suffer a "cruel" brain disorder, which leaves people trapped ...

This study adds to the growing evidence that Alzheimer’s disease may start long before traditional symptoms appear. The fact ...

Cubresa is pleased to announce that it has signed a global Master Interface Agreement with Siemens Healthineers. The ...

Sound and rhythm have great potential in healthcare. Another company to realize this is Lapsi Health. By utilizing sound and ...

The GLP-1 receptor agonist exenatide failed to meet its primary outcome in a phase III trial of Parkinson's disease patients.